Management of pregnancy in cystic fibrosis

Kristina Montemayor, Elizabeth Tullis, Raksha Jain, Jennifer L. Taylor-Cousar

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


With recent therapeutic advances in care, people with cystic fibrosis (CF) are living longer and healthier lives. Development of the cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies has led to improved function of the CFTR protein resulting in improved lung function, decreased rates of pulmonary exacerbations and improved nutritional status for the majority of people with CF. Given improved quality and quantity of life, more people with CF are considering becoming pregnant than ever before. Since the first reported pregnancy in a woman with CF in 1960, the management of pregnancy in CF has been of increased interest and is an active field of research. In this review, we aim to discuss the management of pregnancy in CF. We discuss the optimisation of preconception health, management of maintenance CF therapies, and use of CFTR modulators during pregnancy and lactation. We also describe the management of pulmonary exacerbations during pregnancy as well as the unique management of pregnancy in a post-transplant patient with CF.

Original languageEnglish (US)
Article number220005
Issue number2
StatePublished - Jun 1 2022

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Management of pregnancy in cystic fibrosis'. Together they form a unique fingerprint.

Cite this